Actigraphic Analysis of Treatment Response

• Status: Completed
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Child Psychopharmacology Institute
• Treatments: Risperidone

Criteria

Inclusion Criteria:

• Diagnosis of Kabuki Syndrome

• Medication Naive

• Single subject preparing to receive pharmacological intervention

Exclusion Criteria:

• Inability to wear actigraphy device